Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages 63-71

  Yeap, Bu B ^a,d   Alfonso, Helman ^e   Paul Chubb, S A ^a,f   Gauci, Richard ^d   Byrnes, Elizabeth ^a   Beilby, John P ^f   Ebeling, Peter R ^g   Handelsman, David J ^h   Allan, Carolyn A ⁱ   Grossmann, Mathis ^j   Norman, Paul E ^b   Flicker, Leon ^a,c  

^a FREMANTLE HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d FIONA STANLEY HOSPITAL   (Australia)

^e CURTIN UNIVERSITY   (Australia)

^f SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^j UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; ANDROSTANOLONE; CARBOXY TERMINAL TELOPEPTIDE; ESTRADIOL; LUTEINIZING HORMONE; OSTEOCALCIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG; UNDERCARBOXYLATED OSTEOCALCIN; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE I N-TERMINAL PEPTIDE;

AGED; ARTICLE; AUSTRALIA; BONE REMODELING; BONE TURNOVER; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ESTRADIOL BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOASSAY; INSULIN RELEASE; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOLYSIS; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK ASSESSMENT; RISK REDUCTION; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE; VERY ELDERLY; BLOOD; BONE DENSITY; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

MUS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; COLLAGEN TYPE I; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIHYDROTESTOSTERONE; ESTRADIOL; HUMANS; MALE; OSTEOCALCIN; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; RISK FACTORS; TESTOSTERONE;

EID: 84920617201     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3019     Document Type: Article

References (44)

1. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-469.
2. Gundberg CM, Nieman SD, Abrams S, Rosen H. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Meta b. 1998;83: 3258-3266.
3. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008;105:5266-5270.
4. Ferron M, McKeeMD,Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 d iabetes in mice. Bone. 2012;50:568-575.
5. Oury F, Ferron M, Huizhen W, et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest. 2013;123:2421-2433.
6. Kindblom JM, Ohlsson C, Ljunggren O, et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res. 2009;24:785-791.
7. Kanazawa I, Yamaguchi T, Yamamoto M, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 200 9; 94:45-49.
8. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009;94:827-832.
9. Saleem U, Mosley TH Jr., Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol. 201 0; 30:1474-1478.
10. Yeap BB,Chubb SA,Flicker L,et al. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels Eur J Endocrinol. 2010 163 265-272.
11. Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-Aged male subjects. Diabetes Metab Res Rev. 2009;25:768-772.
12. Shea MK, Gundberg CM, Meigs JB, et al. Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr. 2009;90:1230-1235.
13. Kanazawa I, Yamaguchi T, Yamauchi M, et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int. 2011; 22:187-194.
14. Bulló M, Moreno-Navarette JM, Fernández-Real JM, Salas-Salvadó J. Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and-cell function in elderly men at high cardiovascular risk. Am J Clin Nutr. 2012;95:249-255.
15. Díaz-Ló pez A, Bulló M, Juanola-Falgarona M, et al. Reduced serum concentrations of carboxylated and undercarboxylated osteocalcin are associated with risk of developing type 2 diabetes mellitus in a high cardiovascular risk population: a nested case-control study. J Clin Endocrinol Metab. 2013;98:4524-4531.
16. Levinger I, Jerums G, Stepto NK, et al. The effect of acute exercise on undercarboxylated osteocalcin and insulin sensitivity in obese men. J Bone Miner Res. e-published 2014 May 24. doi:10.1002/jbmr.2285. [published May 24, 2014], doi: 10.1002/jbmr.2285.
17. Kanazawa I, Tanaka K, Ogawa N, Yamauchi M, Yamaguchi T, Sugimoto T. Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus. Osteoporos Int . 2013;24:1115-1119.
18. Swerdloff RS,WangC. Free testosterone measurement by the analog displacement direct assay: old concerns and new evidence. Clin Chem. 2008;54:458-460.
19. Fink HA, Ewing SK, Ensrud KE, et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab. 2006;91:3908-3915.
20. Meier C, Nguyen TV, Handelsman DJ, et al. Endogenous sex hormones and incident fracture risk in older men: The Dubbo Osteoporosis Epidemiology Study. Arch Intern Med. 2008;168:47-54.
21. M ellström D, Vandenput L, Mallmin H, et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res. 2008;23:1552-1560.
22. LeBlanc ES, Nie lsen CM, Marshall LM, et al. The effects of serum testosterone, estradiol and sex hormone-binding globulin levels in fracture risk in older men. J Clin Endocrinol Metab. 2009;94:3337-3346.
23. Vasika ran S, Eastell R, Bruyére O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22:391-420.
24. Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z, Jamrozik K. Cohort profile: The Health InMenStudy (HIMS). Int J Epidemiol. 2009;38:48-52.
25. Holman CD, Bass AJ, Rosman DL, et al. A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. Aust Health Rev. 2008;32:766-777.
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR.Anew method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
27. Yeap BB, Alfonso H, Chubb SA, et al. Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohor t of older men. J Clin Endocrinol Metab. 2012;97:4030-4039.
28. Ly LP, Sartorius G, Hull L, et al. Accuracy of calculated free testosterone formulae in men. Clin Endocrinol (Oxf). 2010;73:382-388.
29. Yeap BB, Chubb SA, Hyde Z, et al. Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: The Health In Men Study. Eur J Endocrinol. 2009;161: 591-598.
30. Wong YY, McCaul KA, Yeap BB, Hankey GJ, Flicker L. Low vitamin D status is an independent predictor of increased frailty and all-cause mortality in older men: The Health In M en Study. J Clin Endocrinol Metab. 2013;98:3821-3828.
31. Armitage P,Berry G,Matthews JN. Statistical Methods in Medical Research 4th ed. Oxford, UK Blackwell Science 2002 83-146.
32. Mori K, Emoto M, Motoyama K, et al. Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes. Diabetol Metab Syndr. 2012;4:53.
33. Iki M, Tamaki J, Fujita Y, et al. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int. 2012; 23:761-770.
34. De Toni L, De Filippis V, Tescari S, et al. Uncarboxylated osteocalcin stim ulates 25-hydroxy vitamin D production in Leydig cell line through a GPRC6A-dependent pathway. Endocrinology. 2014; 155:4266-4274.
35. Buday B, Pach FP, Literati-Nagy B, Vitai M, Vecsei Z, Ko ranyi L. Serum osteocalcin is associated with improved metabolic state via adiponectin in females versus testosterone in males. Gender specific nature of the bone-energy homeostasis axis. Bone. 2013;57:98-104.
36. Schwetz V, Gumpold R, Graupp M, et al. Osteocalcin is not a strong determinant of serum testosterone and sperm count in men from infertile couples. Andrology. 2013;1:590-594.
37. Khosla S. Update in male osteoporosis. J Clin Endocrinol Metab. 2010;95:3-10.
38. Amin S, Zhang Y, Felson DT, et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med. 2006;119:426-433.
39. Cauley JA, Ewing SK, Taylor BC, et al. Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density-the Osteoporotic Fractures in Men Study. J Clin Endocrinol Metab. 2010;95:4314-4323.
40. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81-S90.
41. Vermeulen A, Ve rdonck G. Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. J Clin Endocrinol Metab. 1992;74:939-942.
42. Dunstan D, Zimmet P, Welborn T, et al. Diabesity and Associated Disorders in Australia-2000: The Accelerating Epidemic. The Australian Diabetes, Obesity and Lifestyle Study. Melbourne, Australia: International Diabetes Institute. 2000;7-12.
43. Confav reux CB, Szulc P, Casey R, et al. Higher serum osteocalcin is associated with lower abdominal aortic calcification progression and longer 10-year survival in elderly men of the MINOS cohort. J Clin Endocrinol Metab. 2013;98 :1084-1092.
44. Schwartz AV, Vittinghoff E, Bauer DC, et al. Association of BMD and FRAX score with risk of fracture in older adults with Type 2 diabetes. JAMA. 2011;305:2184-2192.